Bretazenil 99%
ISO FDA 36 Inquiries
84379-13-5
Pharmaceutical Grade
99%
shanghai
25kg
2023-03-31
chemicals,low price LCZ696 Intermediate,NICOTINAMIDE RIBOSIDE,NR,,4-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine,Romidepsin (FK228, Depsipeptide),Alpha-GPC
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCertificatesBasic Info
-
Product Name:
Bretazenil
Other Name:9H-Imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylic acid,8-bromo-11,12,13,13a-tetrahydro-9-oxo-,1,1-dimethylethyl ester,(13aS)-;9H-Imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylic acid,8-bromo-11,12,13,13a-tetrahydro-9-oxo-,1,1-dimethylethyl ester,(S)-;Ro 16-6028;Bretazenil;Ro 16-6028/000
CAS No.:84379-13-5
Molecular Formula:C19H20BrN3O3
InChIKeys:InChIKey=LWUDDYHYYNNIQI-ZDUSSCGKSA-N
Molecular Weight:418.289
Exact Mass:418.28
UNII:OSZ0E9DGOJ
DSSTox ID:DTXSID6046266
Categories:
Characteristics-
PSA:
64.4
XLogP3:2.52
Appearance:white solid
Density:1.6±0.1 g/cm3
Boiling Point:594.3±50.0 °C at 760 mmHg
Flash Point:313.2±30.1 °C
Refractive Index:1.685
Water Solubility:DMSO: 24 mg/mL, soluble
Storage Conditions:2-8°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
chemicals,low price LCZ696 Intermediate,NICOTINAMIDE RIBOSIDE,NR,,4-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine,Romidepsin (FK228, Depsipeptide),Alpha-GPC
-
Location:
No 7 ,Huacai International Building,Dengcai Road,Sandun,Westlake District,Hangzhou,Zhejiang
-
Payment Terms:
L/C,100% TT in advance
-
Average lead Time:
30
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
101-200
-
Year of Establishment:
2011
-
Certifications:
ISO,FDA,CE
Gihi Chemicals: is specialized in the production of ester products which are used in the daily dietary supplements chemicals ,cosmetic products and skincare products since 1999.
Since 2010,GIHI CHEMICALS , begun to focus on the development and production of high-quality healthy Dietary supplements for our global high-reputation customers. The purity of all healthy Dietary supplements we provide has reached more than 99% purity. From the beginning of our products’ development, our technical engineers have chosen and design the production routes to ensure that we have been able to use biological, enzyme and water-phase green synthesis methods during the large production process to ensure that our health dietary supplements is truly high-quality ,green &environmental friendly, which are truly good and health to the human body.
Now our company has:
1 sales & management center + 3 research centers+ 4 production factories.
with ISO9001 & FDA certificate & CE certificate, accordance with GMP requirements.
1 Sales &Management center:
Add:No.567 Dengcai Street, Sandun, Westlake District, Hangzhou 310030, Zhejiang, China.
Research Center 1: (Chemical synthesis lab)
No.6, Chanyexietongchuanxing Center, Kangyang Road, Shangyu Economic and Technological Development Zone, Shaoxing, Zhejiang,China.
This research center: is specialized in chemical synthesis, our this research center could synthesis more than 300 new chemical products for many china pharmaceutical companies every year.
Research Center 2:(For Enzyme biology technical and Enzyme catalyst technical)
No.7, Lixiangxi Road, changsha Economic and Technological Development Zone, Changsha, Hunan.
Our this research center is committed to the applications of immobilized enzymes technology to the development of products such as peptides, polysaccharides, and non-natural amino acids. The products developed are widely used in medicine, health products, cosmetics, food, feed and other industries. The company adopts multidisciplinary technologies of chemistry, materials science and life sciences, which helps to meet the demand of green production while improving product quality and economic benefits. And also helps to reduces the emission of "three industrial pollution" greatly.
Research Center 3:(Biology enzyme-catalytic products)
No.2 Bio-hatch Building,No.10 Gaoxinzhongyidao, Yuehai Street,Nanshan District, Shenzhen, Guangdong, China.
This research center is specialized in biosynthesis technology as the core technology, and multi-disciplinary cross-application as target. We are the first batch company in the world to apply enzyme catalysis technology to the large-scale production of peptides, carbohydrates and nucleic acids and other special functional raw materials, and actively explore products in new application in the field. In this center, we used enzyme catalyst production methods to produce many high lever products, such as: NMN, (S)-Prox-ylane, Ectoin, Ergothioneine,etc.
-
-
Inquiry History36 Inquiries
Country Product Purchase Quantity Date Posted
Germany
Bretazenil 84379-13-5 99%
1 KG Nov 7, 2025
United States
bretazenil
100 G Apr 22, 2026
United States
Bretaznil
10 G Feb 24, 2026
United States
Bretazenil
5 G Dec 25, 2025
Lithuania
Bretazenil
5 G Feb 17, 2025
Canada
Bretazenil Wholsale
10 MG Dec 1, 2024
United States
high purity hot sale Bretazenil 99% high quality see COA
0.5 KG Nov 13, 2023
United States
high purity hot sale Bretazenil 99% high quality see COA
10 G Nov 7, 2023
United Kingdom
Bretazenil
5 MG Apr 29, 2026
United States
Bretazenil
2 G Feb 25, 2026
United States
bretaznil powder
10 G Feb 24, 2026
United Kingdom
Bretazenil
20 G Dec 29, 2025
United States
Bretazenil
5 G Dec 16, 2025
Sweden
Bretazenil
20 G Sep 28, 2025
Germany
Bretazenil
20 G Jul 19, 2025
United States
Bretazenil
10 G Apr 15, 2025
Lithuania
Bretazenil
1 G Feb 18, 2025
United States
Bretazenil
10 G Jan 16, 2025
Canada
Bretazenil
10 G Jan 6, 2025
Canada
Bretazenil
250 MG Oct 1, 2024 Post an enquiry for this product